Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1960 Feb 29;111(3):419–427. doi: 10.1084/jem.111.3.419

IMMUNOLOGIC PRODUCTION OF ANTIANGIOTENSIN

I. PREPARATION OF ANGIOTENSIN-PROTEIN COMPLEX ANTIGEN

Sharad D Deodhar 1
PMCID: PMC2137262  PMID: 13721953

Abstract

Angiotensin II was coupled with bovine γ-globulin (BGG) through the following series of reactions. See PDF for Structure By determinations of the aromatic amine and tyrosine contents of p-aminobenzoylangiotensin II, the number of p-aminobenzoyl residues introduced per molecule of angiotensin II was calculated. Absorption spectra (between 250 and 500 mµ) of BGG complexes of p-aminobenzoylangiotensin II and six different para substituted aromatic amines were compared. Specific activities (dog units/millimicromole) of the different intermediate products were determined. Presence of a terminal, free amino group does not appear to be an absolute requirement for the biological activity of angiotensin II, since substitution of a p-aminobenzoyl radical in this group yields a product with 40 to 50 per cent of the activity of the parent compound. Angiotensin I, on the other hand, is completely inactivated under identical circumstances. Possible implication of this finding has been discussed.

Full Text

The Full Text of this article is available as a PDF (465.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Braun-Menendez E., Fasciolo J. C., Leloir L. F., Muñoz J. M. The substance causing renal hypertension. J Physiol. 1940 Jul 24;98(3):283–298. doi: 10.1113/jphysiol.1940.sp003850. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. GOLDBLATT H., HAAS E., LAMFROM H. Antirenin in man and animals. Trans Assoc Am Physicians. 1951;64:122–125. [PubMed] [Google Scholar]
  3. GOLDBLATT H., LAMFROM H., HAAS E. Physiological properties of renin and hypertension. Am J Physiol. 1953 Oct;175(1):75–83. doi: 10.1152/ajplegacy.1953.175.1.75. [DOI] [PubMed] [Google Scholar]
  4. HELMER O. M. Studies on renin antibodies. Circulation. 1958 Apr;17(4 Pt 2):648–652. doi: 10.1161/01.cir.17.4.648. [DOI] [PubMed] [Google Scholar]
  5. LAMFROM H., HAAS E., GOLDBLATT H. Studies on antirenin. Am J Physiol. 1954 Apr;177(1):55–64. doi: 10.1152/ajplegacy.1954.177.1.55. [DOI] [PubMed] [Google Scholar]
  6. Landsteiner K., van der Scheer J. ON THE SEROLOGICAL SPECIFICITY OF PEPTIDES. II. J Exp Med. 1934 May 31;59(6):769–780. doi: 10.1084/jem.59.6.769. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Landsteiner K., van der Scheer J. ON THE SEROLOGICAL SPECIFICITY OF PEPTIDES. J Exp Med. 1932 Apr 30;55(5):781–796. doi: 10.1084/jem.55.5.781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. SKEGGS L. T., Jr, KAHN J. R., SHUMWAY N. P. The preparation and function of the hypertensin-converting enzyme. J Exp Med. 1956 Mar 1;103(3):295–299. doi: 10.1084/jem.103.3.295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. SKEGGS L. T., Jr, LENTZ K. E., KAHN J. R., SHUMWAY N. P., WOODS K. R. The amino acid sequence of hypertensin. II. J Exp Med. 1956 Aug 1;104(2):193–197. doi: 10.1084/jem.104.2.193. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES